1. McCann SR, Lawler M . Monitoring outcome: MRD, Chimaerism and relapse. In: Apperley J, Carreras E, Gluckman E, Grathohl A, Masszi T (eds). Haematopoietic Stem Cell Transplantation. EBMT: Berlin, 2004, pp 196–212.
2. Khan F, Agarwal A, Agrawal S . Significance of chimerism hematopoietic stem cell transplantation: new variation on an old theme. Bone Marrow Transplant 2004; 34: 1–12.
3. Senitzer D, Gaidulis L . Short tandem repeat analysis of engraftment in allogeneic stem cell transplantation. ASHI Quart 2001; 25: 49–54.
4. Kristt D, Narinski R, Or H . Differential levels of chimeric tolerance in a single patient: how much change in quantitative chimerism values is enough for clinical significance? 32nd Annual Meeting of the European Group for Blood an Marrow Transplantation, Abstract R1157. Hamburg, 2006.
5. Lion T, Muller-Bérat N . Debate Round-Table: chimerism testing after allogeneic stem cell transplantation: importance of timing and optimal technique for testing in different clinical–biological situations. Leukemia 2003; 17: 612–633.